[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369751-105":59,"doc-detail-369751-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","secondary-neoplasms-in-mycosis-fungoides-evaluating-risk-factors-and-phototherapy-impact-in-a-comparative-study","Secondary neoplasms in mycosis fungoides - evaluating risk factors and phototherapy impact in a comparative study","","Patients with mycosis fungoides (MF) are at increased risk of secondary neoplasms. A comparative retrospective analysis evaluated MF patients with and without secondary neoplasms and a non-MF control group to measure prevalence and identify risk factors. Data from 252 MF patients and 278 controls included demographics, MF treatments, phototherapy details, secondary neoplasm occurrence and detection time, and mortality. The prevalence of secondary neoplasms was higher in the MF group (13.9%) versus controls (3.6%, p\u003C0.001). Older age at MF diagnosis and elevated beta-2 microglobulin levels were associated with neoplasms, while phototherapy type showed no significant association. Higher mortality in MF patients with secondary neoplasms supported the need for early detection and vigilant monitoring.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/secondary-neoplasms-in-mycosis-fungoides-evaluating-risk-factors-and-phototherapy-impact-in-a-comparative-study/369751/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/secondary-neoplasms-in-mycosis-fungoides-evaluating-risk-factors-and-phototherapy-impact-in-a-comparative-study/369751.png","ImageObject",300,407,{"name":92,"@type":93},"supergirl","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study designed to evaluate in mycosis fungoides (MF) patients?","Question",{"text":112,"@type":113},"The study assessed the prevalence of secondary neoplasms in MF and investigated associated risk factors, using a comparative retrospective approach.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the prevalence of secondary neoplasms differ between MF patients and controls?",{"text":117,"@type":113},"Secondary neoplasms were significantly more common in MF patients (13.9%) than in the control group (3.6%), with p\u003C0.001.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were linked to the development of secondary neoplasms in MF patients?",{"text":121,"@type":113},"Risk increased with older age at MF diagnosis and elevated initial and final beta-2 microglobulin levels.",{"name":123,"@type":110,"acceptedAnswer":124},"Was phototherapy associated with secondary neoplasm development?",{"text":125,"@type":113},"Phototherapy type showed no significant association with the presence of secondary neoplasms in MF patients.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},369751,1790710348,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":46,"preview_page_count":19,"preview_urls":148},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Annals of Hematology (2025) 104:3829–3836  \n[https://doi.org/10.1007/s00277-025-06442-7](https://doi.org/10.1007/s00277-025-06442-7)  \nRESEARCH  \nSecondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study  \nAyda Acar1 · Ayris Ozturk1,2 · Gunseli Ozturk1 · Ilgen Ertam Sagduyu1 · Bengu Gerceker Turk3 · Banu Yaman4 · Taner Akalın4  \nReceived: 25 February 2025 / Accepted: 27 May 2025 / Published online: 17 June 2025 © The Author(s) 2025  \nAbstract  \nPatients with mycosis fungoides (MF) are at an increased risk of developing secondary neoplasms. We conducted a comparative analysis between MF patients with and without secondary neoplasms and non-MF patients to assess secondary neoplasm occurrence and identify potential risk factors. We aimed to evaluate the prevalence of secondary neoplasms and investigate associated risk factors in MF patients. Demographic data, treatments, phototherapy details, neoplasm occurrence and detection time, and mortality rates were collected and retrospectively analyzed for 252 MF and 278 control patients. The prevalence of secondary neoplasms was significantly higher in the MF group (13.9%) compared to the control group (3.6%) (p\u003C 0.001) . MF patients with neoplasms had a higher average age and older age at MF diagnosis (p = 0.003 and 0.016, respectively) . Phototherapy type showed no significant association with neoplasm presence. Elevated initial and final beta-2 microglobulin levels were observed in MF patients with neoplasms (p= 0.002 and 0.005, respectively). MF patients have a higher risk of developing secondary neoplasms compared to controls. Risk increases with older age at MF diagnosis and elevated beta-2 microglobulin levels. Phototherapy was not associated with the development of secondary neoplasms in MF patients. MF patients with secondary neoplasms exhibit higher mortality rates, underscoring the importance of early detection and vigilant monitoring.  \nKeywords Mycosis fungoides · Secondary neoplasm · Malignancy · Phototherapy · Beta 2-microglobulin  \nIntroduction  \nMycosis fungoides (MF) is the most prevalent form of cutaneous T cell lymphoma (CTCL) . Due to its diverse clinical presentations and non-specific histopathological features, particularly in the early stages, accurate diagnosis is often  \ndelayed. However, survival rates in the early stages of MFare generally favourable [1] .  \nPatients with MF are at risk of developing secondary malignancies, especially non-melanoma skin cancer (NMSC), non-Hodgkin lymphoma (NHL) [2-4], Hodgkin lymphoma (HL) [2-5], lung cancer [2-5], bladder cancer [2-4], and malignant melanoma (MM) [2-4, 6, 7] . The  \n􀀍 AydaAcar[ayda.acar@ege.edu.tr](ayda.acar@ege.edu.tr)  \nAyris Ozturk [ayrisyanmaz@gmail.com](ayrisyanmaz@gmail.com)[ ](ayrisyanmaz@gmail.com)Gunseli Ozturk  \n[gunyayla@yahoo.com](gunyayla@yahoo.com)  \nIlgen Ertam Sagduyu  \n[ilgenertam@gmail.com](ilgenertam@gmail.com)[ ](ilgenertam@gmail.com)Bengu Gerceker Turk [bengugerceker@yahoo.com](bengugerceker@yahoo.com)  \nBanu Yaman  \n[drbanuyaman@gmail.com](drbanuyaman@gmail.com)  \nTaner Akalın  \n[taner.akalin@ege.edu.tr](taner.akalin@ege.edu.tr)  \n1 Department of Dermatology, Ege University Faculty of Medicine, 35100 Izmir, Turkey  \n2 Department of Dermatology and Venereology, Usak University Training and Research Hospital, Usak, Turkey  \n3 Special Office, Izmir, Turkey  \n4 Department of Pathology, Ege University Faculty of Medicine, Izmir 35100, Turkey  \ndevelopment of secondary malignancies in patients with MF other than MM and NMSC is not primarily associated with the treatments received for MF. Factors such as the immunosuppressive state associated with MF, environmental carcinogen exposure, and shared genetic mutations may contribute to the development of these secondary malignancies [2, 8] . Notably, smoking is a significant risk factor, especially for lung and bladder cancer, and dermatologists are advised to encourage patients with MF to quit","cbCaieAW63x2VS7f","https://ap.wps.com/l/cbCaieAW63x2VS7f","pdf",818005,"English","# Introduction\n# Materials and methods\n# Results\n# Discussion","[{\"question\":\"What was the study designed to evaluate in mycosis fungoides (MF) patients?\",\"answer\":\"The study assessed the prevalence of secondary neoplasms in MF and investigated associated risk factors, using a comparative retrospective approach.\"},{\"question\":\"How did the prevalence of secondary neoplasms differ between MF patients and controls?\",\"answer\":\"Secondary neoplasms were significantly more common in MF patients (13.9%) than in the control group (3.6%), with p\\u003c0.001.\"},{\"question\":\"Which factors were linked to the development of secondary neoplasms in MF patients?\",\"answer\":\"Risk increased with older age at MF diagnosis and elevated initial and final beta-2 microglobulin levels.\"},{\"question\":\"Was phototherapy associated with secondary neoplasm development?\",\"answer\":\"Phototherapy type showed no significant association with the presence of secondary neoplasms in MF patients.\"}]","Secondary neoplasms in mycosis fungoides - evaluating risk factors and phototherapy impact in a comparative study | PDF",1790184350,[149,153,157,161],{"page_no":8,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe21d0a343264b864bf23105ae079f64.webp",983,1305,{"page_no":14,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6e2383ac248ceb8c1cb9491b030b5e3.webp",982,1304,{"page_no":81,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c184dbd0dd225f077c77f3dd2662a9f3.webp",981,1303,{"page_no":19,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74868e3fdc260af1f9791b9a130ba4bf.webp",980,1301]